PROCEPT BioRobotics (PRCT) Invested Capital (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Invested Capital data on file, last reported at $399.3 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $399.3 million, down 9.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $399.3 million (down 9.38% YoY), and the FY2025 annual result was $417.5 million, down 7.98% from the prior year.
• Invested Capital fell to $399.3 million in Q1 2026 per PRCT's latest filing, from $417.5 million in the prior quarter.
• Over five years, Invested Capital peaked at $453.7 million in Q4 2024 and troughed at $207.2 million in Q2 2023.
• A 5-year average of $336.4 million and a median of $315.4 million in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Invested Capital surged 256.3% in 2022, then slipped 28.48% in 2023.
• A 5-year view of Invested Capital shows it stood at $248.3 million in 2022, then jumped by 33.75% to $332.1 million in 2023, then soared by 36.62% to $453.7 million in 2024, then slipped by 7.98% to $417.5 million in 2025, then fell by 4.35% to $399.3 million in 2026.
• Business Quant data shows PRCT's Invested Capital at $399.3 million in Q1 2026, $417.5 million in Q4 2025, and $431.8 million in Q3 2025.